Form D · Biotechnology

Nano Precision Medical, Inc.

Emeryville, CA · CIK 0001600758

Offering snapshot reported Feb 22, 2016 · SEC filing

Reported sold
$2.37M
Offering amount: $2.37M
Investors reported
20
Form D · investor count
Minimum accepted
$1K
Reported outside-investor minimum
First sale
Jan 31, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.18M$2.37MMar 26, 2014: $2,000,000.00Mar 26, 2014Feb 22, 2016: $2,366,583.00Feb 22, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,000,000 → $2,366,583

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 22, 2016Amendment$2,366,583$366,583vs Mar 26, 201420SEC filing
Feb 22, 2016Amendment$2,452,639$452,639vs Mar 25, 201420SEC filing
Feb 9, 2016Amendment$5,717,845$5,717,845vs Feb 8, 201640SEC filing
Feb 8, 2016Amendment$0$0vs Apr 15, 20150SEC filing
Feb 5, 2016Initial$250,000No comparison2SEC filing
Feb 4, 2016Amendment$70,000-$180,000vs Feb 1, 20162SEC filing
Feb 3, 2016Amendment$40,000-$60,000vs Feb 1, 20161SEC filing
Feb 1, 2016Initial$100,000No comparison1SEC filing
Feb 1, 2016Initial$250,000No comparison1SEC filing
Apr 15, 2015Initial$0No comparison0SEC filing
Mar 26, 2014Initial$2,000,000No comparison20SEC filing
Mar 25, 2014Initial$2,000,000No comparison20SEC filing
Mar 24, 2014Initial$2,000,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-214298

Source: Form D, filed Feb 22, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
W. Dean Baker Director
Kathleen Fischer Director, Executive
Kathleen Fisher Executive
Adam Mendelsohn Director, Executive
Aaron Mendelsohn Director
Lily Peng Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5858 Horton Street, Suite 393
Emeryville, CA, 94608